BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
USA - NASDAQ:BVS - US09075A1088 - Common Stock
7.35 USD
-0.22 (-2.91%)
7.35 USD
0 (0%)
Taking everything into account, BVS scores 5 out of 10 in our fundamental rating. BVS was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While BVS is still in line with the averages on profitability rating, there are concerns on its financial health. BVS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
BVS had positive earnings in the past year.
In the past year BVS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.11%, BVS is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
With a decent Return On Equity value of 4.71%, BVS is doing good in the industry, outperforming 75.66% of the companies in the same industry.
BVS's Return On Invested Capital of 6.62% is amongst the best of the industry. BVS outperforms 80.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a Profit Margin of 1.39%. This is in the better half of the industry: BVS outperforms 73.55% of its industry peers.
BVS's Operating Margin of 8.03% is fine compared to the rest of the industry. BVS outperforms 75.13% of its industry peers.
In the last couple of years the Operating Margin of BVS has declined.
Looking at the Gross Margin, with a value of 67.76%, BVS is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
In the last couple of years the Gross Margin of BVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BVS is destroying value.
Compared to 1 year ago, BVS has more shares outstanding
Compared to 5 years ago, BVS has more shares outstanding
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
BVS has an Altman-Z score of 1.20. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
BVS has a Altman-Z score (1.20) which is comparable to the rest of the industry.
The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
BVS has a better Debt to FCF ratio (6.22) than 76.19% of its industry peers.
A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
BVS's Debt to Equity ratio of 1.93 is on the low side compared to the rest of the industry. BVS is outperformed by 82.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.2 |
ROIC/WACC0.78
WACC8.52%
2.3 Liquidity
A Current Ratio of 1.74 indicates that BVS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.74, BVS is doing worse than 68.25% of the companies in the same industry.
A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
The Quick ratio of BVS (1.14) is worse than 71.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
Looking at the last year, BVS shows a small growth in Revenue. The Revenue has grown by 1.58% in the last year.
BVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
BVS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.18% yearly.
The Revenue is expected to grow by 4.48% on average over the next years.
EPS Next Y37.53%
EPS Next 2Y33.95%
EPS Next 3Y28.18%
EPS Next 5YN/A
Revenue Next Year0.32%
Revenue Next 2Y3.71%
Revenue Next 3Y4.48%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.46 indicates a correct valuation of BVS.
Compared to the rest of the industry, the Price/Earnings ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 88.89% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BVS to the average of the S&P500 Index (25.89), we can say BVS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.72, the valuation of BVS can be described as reasonable.
Based on the Price/Forward Earnings ratio, BVS is valued cheaper than 94.18% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.59. BVS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.46 | ||
| Fwd PE | 8.72 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 91.01% of the companies listed in the same industry.
95.77% of the companies in the same industry are more expensive than BVS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.37 | ||
| EV/EBITDA | 9.66 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BVS's earnings are expected to grow with 28.18% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y33.95%
EPS Next 3Y28.18%
5. Dividend
5.1 Amount
BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.35
-0.22 (-2.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners73.56%
Inst Owner Change1.04%
Ins Owners2.54%
Ins Owner Change4.96%
Market Cap607.70M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target14.96 (103.54%)
Short Float %3.24%
Short Ratio6.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)0%
PT rev (3m)4.76%
EPS NQ rev (1m)-2.27%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)-0.52%
EPS NY rev (3m)-9.43%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.46 | ||
| Fwd PE | 8.72 | ||
| P/S | 1.08 | ||
| P/FCF | 11.37 | ||
| P/OCF | 10.85 | ||
| P/B | 3.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.66 |
EPS(TTM)0.59
EY8.03%
EPS(NY)0.84
Fwd EY11.47%
FCF(TTM)0.65
FCFY8.8%
OCF(TTM)0.68
OCFY9.22%
SpS6.82
BVpS2.01
TBVpS-2.65
PEG (NY)0.33
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.2 |
F-Score8
WACC8.52%
ROIC/WACC0.78
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y37.53%
EPS Next 2Y33.95%
EPS Next 3Y28.18%
EPS Next 5YN/A
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.32%
Revenue Next 2Y3.71%
Revenue Next 3Y4.48%
Revenue Next 5YN/A
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.75%
EBIT Next 3Y12.98%
EBIT Next 5YN/A
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status of BIOVENTUS INC - A (BVS) stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
How financially healthy is BIOVENTUS INC - A?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.
What is the earnings growth outlook for BIOVENTUS INC - A?
The Earnings per Share (EPS) of BIOVENTUS INC - A (BVS) is expected to grow by 37.53% in the next year.